|
|
|
Volumn 6, Issue 3, 1996, Pages 152-157
|
|
CPT-11: the European clinical development.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
DRUG DERIVATIVE;
IRINOTECAN;
BREAST TUMOR;
COLORECTAL TUMOR;
DOSE RESPONSE;
DRUG ADMINISTRATION;
EUROPE;
FEMALE;
HUMAN;
LUNG TUMOR;
PANCREAS TUMOR;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
REVIEW;
UTERINE CERVIX TUMOR;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
BREAST NEOPLASMS;
CAMPTOTHECIN;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
COLORECTAL NEOPLASMS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
EUROPE;
FEMALE;
HUMANS;
LUNG NEOPLASMS;
PANCREATIC NEOPLASMS;
UTERINE CERVICAL NEOPLASMS;
|
|
EID: 0030154540
PISSN: 10600051
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (2)
|
|
References (44)
|
